==========================================START OF PAGE 1======

                SECURITIES AND EXCHANGE COMMISSION
                         Washington, D.C.

SECURITIES EXCHANGE ACT OF 1934
RELEASE NO. 38260 / February 10, 1997

     The Securities and Exchange Commission today ordered the
temporary suspension, pursuant to Section 12(k) of the Securities
Exchange Act of 1934 ("Exchange Act"), of trading in the
securities of Twenty First Century Health, Inc. ("TFCH"),
beginning at 9:00 a.m. EDT on February 10, 1997 and concluding at
11:59 p.m. EDT on February 24, 1997.  TFCH is located in Las
Vegas, Nevada, and holds itself out as a new products development
company in the field of health related hygienic, home diagnostic,
nutritional supplement and medical technology products.  TFCH's
present market capitalization is approximately $40 million.

     The Commission ordered this trading suspension because of
questions raised as to the adequacy and accuracy of publicly-
disseminated information concerning, among other things: (1)
TFCH's financial condition; (2) the existence, effectiveness, and
marketability of a medical device for testing blood sugar
purportedly licensed by TFCH; (3) the size of the market for that
device; and (4) the ownership, value, and business of certain
companies purportedly acquired by TFCH.  The Commission
determined that the public interest and the protection of
investors requires a suspension of trading in TFCH securities.

     The Commission cautions broker-dealers, shareholders, and
prospective purchasers that they should carefully consider the
foregoing information along with all other currently available
information and any information subsequently issued by the
company.

     Further, brokers and dealers should be alert to the fact
that, pursuant to Rule 15c2-11 under the Exchange Act, at the
termination of the trading suspension, no quotation may be
entered unless and until they have strictly complied with all of
the provisions of the rule.  If any broker or dealer has any
questions as to whether or not he has complied with the rule, he
should not enter any quotation but immediately contact the staff
of the Securities and Exchange Commission in Washington, D.C.  If
any broker or dealer is uncertain as to what is required by Rule
15c2-11, he should refrain from entering quotations relating to
TFCH's securities until such time as he has familiarized himself
with the rule and is certain that all of its provisions have been
met.  If any broker or dealer enters any quotation which is in
violation of the rule, the Commission will consider the need for
prompt enforcement action.